Hennion & Walsh Asset Management’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Hennion & Walsh Asset Management’s Portfolio ODT Stock Details ODT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-69,264	Closed	-$91K	–	819
2022 Q1	$91K	Sell	69,264 -3,486	-5%	-$4.38K	﹤0.01%	763
2021 Q4	$98K	Sell	72,750 -4,602	-6%	-$10.9K	﹤0.01%	736
2021 Q3	$225K	Sell	77,352 -3,828	-5%	-$12.7K	0.01%	688
2021 Q2	$283K	Buy	81,180 +3,038	+4%	+$10.4K	0.02%	632
2021 Q1	$267K	Buy	+78,142	New	+$1.48M	0.02%	620

Hennion & Walsh Asset Management's ODT Position: Q2 2022 in Review

Hennion & Walsh Asset Management sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q2 2022, closing a stake of 69,264 shares — an estimated $91K sold.

Hennion & Walsh Asset Management first reported a position in ODT in Q1 2021 and held it in 5 quarters. The position peaked at $283K in Q2 2021. 0 funds tracked by Wall St. Rank hold ODT as of Q2 2022.

Hennion & Walsh Asset Management reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Hennion & Walsh Asset Management sold 69,264 Odonate Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $91K.
Hennion & Walsh Asset Management first reported a position in Odonate Therapeutics, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
Hennion & Walsh Asset Management's Odonate Therapeutics, Inc. Common Stock position peaked at $283K in Q2 2021.
0 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2022, filed 19 Jul 2022.